2024-2025 COVID-19 mRNA Vaccine Effectiveness against Severe Disease - PubMed
6 hours ago
- #mRNA Vaccine
- #Vaccine Effectiveness
- #COVID-19
- Study evaluated the effectiveness of the 2024-2025 COVID-19 mRNA vaccine against severe disease.
- Used electronic health records from a South Carolina health system for analysis.
- Matched vaccinated and unvaccinated individuals based on demographic and clinical factors.
- Vaccine effectiveness was 41.3% against emergency department visits or more severe care.
- Effectiveness was 46.1% against hospitalization.
- Demonstrated moderate protection in a population with high prior exposure.
- Highlighted the need for increased vaccination coverage, especially among high-risk groups.